Delivery Order SPE2DB22D2206-SPE2DB24FKJ74

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,163.08 firm-fixed-price delivery order contract to Amerisource Bergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product, with a period of performance through September 13, 2024. This contract award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and Amerisource Bergen,...
The U.S. Defense Logistics Agency (DLA) awarded a $23,436.74 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $6,942.03 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,040.77 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor to provide a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,733.44 firm fixed-price delivery order is for RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,742.57 firm fixed-price delivery order contract covers the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $26,824.14 Firm Fixed Price delivery order is for the supply of 4564802382 RINVOQ ER 30 MG TABLET to the government. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,313.23 delivery order contract is for the supply of RINVOQ ER 45 MG TABLET, a pharmaceutical product. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKJ74
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $30,248.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET, with a performance period through September 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which provides a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical pharmaceuticals and medical supplies to various federal agencies and healthcare programs.

Generated 12/16/24, 2:34 PM